Optimizing the Use of Rituximab and Other Anti-CD20 Antibodies

被引：0
|
作者：
Richards, Kristy L. [1 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
ONCOLOGIST | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [21] Anti-CD20 (rituximab) treatment improves atopic eczema
    Simon, D.
    Hoesli, S.
    Yawalkar, N.
    Simon, H.
    [J]. ALLERGY, 2008, 63 : 21 - 21
  • [22] Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases
    Kasperkiewicz, M.
    Zillikens, D.
    [J]. HAUTARZT, 2007, 58 (02): : 115 - +
  • [23] Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders
    Dierickx, Daan
    Delannoy, Andre
    Saja, Khalid
    Verhoef, Gregor
    Provan, Drew
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (03) : 278 - 291
  • [24] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [25] Anti-CD20 monoclonal antibodies: reviewing a revolution
    Casan, J. M. L.
    Wong, J.
    Northcott, M. J.
    Opat, S.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2820 - 2841
  • [26] Mechanisms of killing by anti-CD20 monoclonal antibodies
    Glennie, Martin J.
    French, Ruth R.
    Cragg, Mark S.
    Taylor, Ronald P.
    [J]. MOLECULAR IMMUNOLOGY, 2007, 44 (16) : 3823 - 3837
  • [27] Use of anti-CD20 monoclonal antibodies (Rituximab) in the treatment of severe illnesses correlated to Epstein-Barr Virus infections
    Giraldi, E.
    Provenzi, M.
    Cornelli, P.
    Ravasio, E.
    Morali, L.
    Ruggeri, M.
    Foglia, C.
    Cavalleri, L.
    Codazzi, D.
    Rambaldi, A.
    Notarangelo, L. D.
    Torre, G.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 43 - 43
  • [28] Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (04) : 444 - 449
  • [29] Treatment of multiple sclerosis with Anti-CD20 antibodies
    Barun, Barbara
    Bar-Or, Amit
    [J]. CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
  • [30] Rituximab (anti-CD20) zur Behandlung von bullösen AutoimmundermatosenRituximab (anti-CD20) for the treatment of autoimmune bullous diseases
    M. Kasperkiewicz
    D. Zillikens
    [J]. Der Hautarzt, 2007, 58 (2): : 115 - 121
12345